PTIX insider filings

Protagenic Therapeutics, Inc.\new — 19 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-08-24. Screen PTIX transaction legs live →

Insider transaction summary — last 90 days

2026-08-23 to 2026-11-21, from the filings listed below: 1 insider filing (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
ARMEN GARO H — EXEC. CHAIR & PRINCIPAL OFF, Director11 leg · 20,000 sh · $13,000——

Recent insider filings — Protagenic Therapeutics, Inc.\new

FiledFormInsiderReported transactionsSource
2026-08-244ARMEN GARO H — EXEC. CHAIR & PRINCIPAL OFF, DirectorPurchase (P): 20,000 @ $0.65EDGAR
2026-08-204ARMEN GARO H — EXEC. CHAIR & PRINCIPAL OFF, DirectorPurchase (P): 16,634 @ $0.59EDGAR
2026-08-204ARMEN GARO H — EXEC. CHAIR & PRINCIPAL OFF, DirectorPurchase (P): 2,700 @ $0.35EDGAR
2026-08-124ARMEN GARO H — EXEC. CHAIR & PRINCIPAL OFF, DirectorPurchase (P): 2,220 @ $0.32EDGAR
2026-08-104ARMEN GARO H — EXEC. CHAIR & PRINCIPAL OFF, DirectorPurchase (P): 685 @ $0.22EDGAR
2026-08-064ARMEN GARO H — EXEC. CHAIR & PRINCIPAL OFF, DirectorPurchase (P): 5,000 @ $0.26EDGAR
2026-08-034ARMEN GARO H — EXEC. CHAIR & PRINCIPAL OFF., DirectorPurchase (P): 26,291 @ $0.18EDGAR
2024-04-014WRIGHT TIMOTHY R — DirectorGrant/award (A): 21,250 (derivative) @ $1.74EDGAR
2024-03-294Stein Robert Benjamin — DirectorGrant/award (A): 75,000 (derivative) @ $1.74EDGAR
2024-03-294Corvese Brian — DirectorGrant/award (A): 43,750 (derivative) @ $1.74EDGAR
2024-03-294Buell Jennifer — DirectorGrant/award (A): 75,000 (derivative) @ $1.74EDGAR
2024-03-294Barrage Khalil — DirectorGrant/award (A): 22,500 (derivative) @ $1.74EDGAR
2024-03-294Arrow Alexander K. — Chief Financial OfficerGrant/award (A): 100,000 (derivative) @ $1.74EDGAR
2024-03-294ARMEN GARO H — Executive Chairman, Director, 10% ownerGrant/award (A): 250,000 (derivative) @ $1.74EDGAR
2023-10-134Arrow Alexander K. — Chief Financial OfficerPurchase (P): 8,000 @ $0.81EDGAR
2022-05-184Arrow Alexander K. — Chief Financial OfficerPurchase (P): 23,000 @ $0.71 · Purchase (P): 8,000 @ $0.72EDGAR
2021-06-014Barrage Khalil — DirectorGrant/award (A): 180,000 (derivative) @ $0EDGAR
2021-05-054Barrage Khalil — DirectorOption exercise (M): 45,000 @ $1.25 · Option exercise (M): 150,000 @ $1.25 · Option exercise (M): 45,000 @ $1.75 · Option exercise (M): 120,000 @ $1.75 · Option exercise (M): 45,000 (derivative) @ $0 · Option exercise (M): 150,000 (derivative) @ $0 · +2 moreEDGAR
2021-05-034Arrow Alexander K. — Chief Financial OfficerPurchase (P): 1,000 @ $2.29 · Purchase (P): 1,000 @ $2.29EDGAR

Recent 8-K events — Protagenic Therapeutics, Inc.\new

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-178-K1.01 — Entry into a Material Definitive Agreement
3.02 — Unregistered Sales of Equity Securities
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-11-068-K1.01 — Entry into a Material Definitive Agreement
2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-208-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-04-078-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2026-03-038-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2026-02-248-K1.01 — Entry into a Material Definitive Agreement
1.02 — Termination of a Material Definitive Agreement
2.01 — Completion of Acquisition or Disposition of Assets
3.02 — Unregistered Sales of Equity Securities
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-01-058-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
2025-11-268-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2025-11-058-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2025-10-318-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=PTIX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs